US Patent

US10130585 — Methods of treating and/or preventing cardiovascular disease

Method of Use · Assigned to Murray and Poole Enterprises Ltd · Expires 2034-05-09 · 8y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammals using novel formulations.

USPTO Abstract

Methods of treating or preventing cardiovascular disease and/or inflammatory disease in mammalian subjects comprising the administration of the novel formulations disclosed herein are provided.

Drugs covered by this patent

Colcrys (COLCHICINE) · Scilex Pharms

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3642`	—	Colcrys

Patent Metadata

Patent number: US10130585
Jurisdiction: US
Classification: Method of Use
Expires: 2034-05-09
Drug substance claim: No
Drug product claim: No
Assignee: Murray and Poole Enterprises Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.